Healing Hope International is a Texas nonprofit research and education organization focused on advancing the understanding of emerging therapies through real world evidence and global clinical collaboration.
We support the ethical collection and analysis of observational data across international care settings to better characterize safety, outcomes, and patient reported experiences associated with innovative therapeutic approaches.
Our work contributes to bridging scientific research, clinical practice, and patient reported outcomes by supporting transparent, data driven research in areas where treatment options remain limited.
We collaborate with patients, clinicians, and researchers to support observational studies, global research initiatives, and responsible data collection aligned with applicable ethical and regulatory standards.
Healing Hope International does not provide medical treatment, direct clinical care, or determine patient eligibility for therapies.
All treatment decisions are made independently between patients and their licensed healthcare providers.
As a nonprofit charitable organization, we are committed to making a meaningful difference in patients' lives by generating transparent, real world evidence about emerging therapies.
Identify emerging therapies where patients and physicians need better evidence about safety and outcomes.
Explain how clinical trials, expanded access, and other regulatory pathways work so families can discuss options with their own physicians.
Capture the experiences of patients and families through validated patient reported outcomes.
Collect observational data from international research settings and publish the results openly for the public and the scientific community.
A long term observational registry, built around a new validated patient reported outcomes measure, following children and young adults aged 4 to 21.
An observational study of children aged 6 to 12 with hypoxic ischemic encephalopathy, comparing outcomes for children receiving emerging cell therapies from their own physicians with children receiving standard care.
Yearly follow up of every participant for at least five years to understand how outcomes last and to detect late safety concerns.
Free plain language guides, webinars, and summaries of our findings, in English and Spanish.
Positive, negative, or inconclusive, all results are published in peer reviewed open access journals.
Every study is approved by an independent ethics committee and registered on ClinicalTrials.gov before any participant enrolls.
An independent Research Review Committee approves our studies. Donors and companies have no role in design, results, or publication.
Results are released to everyone at the same time. No individual, donor, or company receives findings first.
Healing Hope International facilitates a registry of observational research studies focusing on emerging therapies and real world outcomes. This registry provides a transparent overview of ongoing and completed studies, aligning with our commitment to advancing scientific understanding through ethical data collection.
All listed studies are observational in nature. Healing Hope International does not provide medical treatment or assign interventions. Participation in observational research does not provide access to therapy. All treatment decisions are made independently between patients and their licensed healthcare providers.
Healing Hope International employs a multi-faceted approach to advance understanding of emerging therapies. We combine global expertise with rigorous research and regulatory vigilance.
Leveraging knowledge of international research environments and regulatory frameworks across diverse regions for comprehensive therapy evaluation.
Partnering with clinicians, researchers, and institutions to support ethical observational studies and real-world data collection.
Continuously reviewing public regulatory guidance in key markets (US, Europe, global) to understand evolving research landscapes.
Collecting and analyzing real-world observational data from international settings to inform patient outcomes, safety, and treatment experiences.
Generating data-driven insights through structured observational research to contribute to a broader understanding of emerging therapeutic approaches.
Operating as a nonprofit organization dedicated to advancing research, education, and transparency in emerging therapies through real-world evidence.
Healing Hope International supports observational research collaborations across North America, Europe, Asia, and Africa to better understand how emerging therapies are studied and experienced in diverse healthcare environments. As a nonprofit organization, we collaborate with research partners, institutions, and nonprofit organizations to support data collection and research transparency.
We contribute to observational research efforts through the collection and analysis of real-world data from international research settings. These efforts focus on identifying patterns in patient outcomes, safety, and treatment experiences to inform scientific understanding. Healing Hope International does not conduct or sponsor interventional clinical trials or direct treatment protocols.
We maintain awareness of publicly available regulatory frameworks and ethical guidelines across global regions to support educational understanding of how therapies are evaluated and studied. All regulatory approvals and clinical decisions are managed independently by licensed healthcare providers, sponsors, and appropriate authorities. Healing Hope International does not provide regulatory guidance, prepare submissions, or advise on market access strategies.
Expanded access, also known as compassionate use, is a regulatory pathway that may be considered by licensed physicians for patients with serious or life-threatening conditions when no comparable alternatives are available. Healing Hope International provides general educational information to help patients and families understand when these pathways may be discussed with their healthcare providers.
Expanded access requests are initiated, prepared, and managed exclusively by licensed physicians in coordination with therapy sponsors and the relevant regulatory authorities. Healing Hope International does not prepare, submit, or manage regulatory applications of any kind. We may provide general educational resources regarding publicly available regulatory frameworks only.
All treatment-related coordination — including communication with manufacturers, regulatory authorities, and care teams — is conducted independently by the treating physician and relevant stakeholders. Healing Hope International does not coordinate treatment delivery, manage therapy access, or act as an intermediary between patients and therapy sponsors.
Healing Hope International supports the collection of real-world observational data from patients who independently pursue treatment, where ethically appropriate and consented. This research focuses on understanding safety, patient experiences, and outcomes to contribute to broader scientific knowledge — not to facilitate or guide access to therapies.
Our work is focused exclusively on advancing understanding through observational research and education. We help improve transparency and public awareness of emerging therapies and regulatory pathways. We do not provide medical advice, treatment recommendations, or assistance with accessing investigational therapies.
Board certified Adult Gerontology Acute Care Nurse Practitioner with over a decade of experience in emergency, trauma, cardiovascular, and critical care across leading health systems. She holds a Doctor of Nursing Practice from the University of Arizona, with advanced training from Harvard, Stanford, and Mayo Clinic, and certifications in critical care, neuro-assessment, and regulatory trial management. Dr. Leicher specializes in complex cardiopulmonary, renal, and neurologic cases, integrating conventional and evidence-based complementary therapies.
As Chief Executive Officer, Dr. Leicher provides clear, forward-thinking leadership that guides Healing Hope International's mission and long-term strategy. She ensures that all initiatives are purpose-driven and aligned with the organization's commitment to compassionate healing and global patient empowerment.
Dr. Leicher leads Healing Hope International's patient advocacy and education efforts, with a steadfast commitment to dignity, respect, and informed choice. Her work centers on ensuring that patients and families are heard, supported, and meaningfully represented in research.
Integrity is foundational to Dr. Leicher's leadership. She upholds the highest ethical standards in governance, clinical collaboration, and public communication—particularly in the responsible discussion of emerging medical therapies—fostering trust, transparency, and accountability at every level of the organization.
Through strategic collaboration, Dr. Leicher builds strong partnerships with clinicians, researchers, international treatment centers, and mission-aligned organizations. These collaborations support ethical observational research and strengthen Healing Hope International's global impact.
Dr. Leicher leads intentional, sustainable organizational growth while nurturing a vibrant global community. She cultivates environments that support healing, education, and collaboration, ensuring that the organization's values are reflected across all programs, partnerships, and outreach initiatives.
Tamara is a biochemist and regulatory professional with over 15 years of experience in research. At Healing Hope International she guides the regulatory and ethical framework for our observational studies.
MS in Biopharmaceutical Regulatory Affairs and Chemistry degree with biochemistry focus. Her specialized training enables her to understand the molecular mechanisms of cellular therapies while developing regulatory strategies that satisfy scientific and safety requirements across multiple jurisdictions.
Specialized in cGMP-compliant cell therapy production and cleanroom operations. Tamara has implemented quality management systems for cellular manufacturing facilities in three countries and trains teams on maintaining regulatory compliance throughout the production process.
In her prior professional work, Tamara coordinated international therapy delivery through compassionate use frameworks. She facilitated treatment access for over 200 patients across 14 countries through expanded access programs, physician coordination, and hospital exemptions.
Tamara brings deep regulatory and scientific expertise to Healing Hope International's research program, including study design, ethics committee review, and regulatory documentation. She regularly contributes to policy discussions on how evidence about emerging therapies is generated and shared, and she is committed to rigorous, transparent research that serves patients and families.
Founded by Tamara C Tamas, Biochemist & Clinical Research Professional
ORCID |https://x.com/TamaraCTamas https://orcid.org/0000-0001-8213-6953
Medium | https://medium.com/@tamara.c.tamas
Natalie Hope is a Registered Clinical Counsellor and patient care advocate, specializing in guiding families through the complexities of pediatric brain injury. Her Master's degree in Clinical Counselling and trauma expertise, combined with her personal experience as a mother navigating her son's recovery, provides a unique blend of professional insight and heartfelt empathy.
Natalie champions a holistic approach that integrates clinical counselling, robust patient advocacy, and spiritual support, believing that true healing encompasses emotional, physical, and spiritual well-being for the entire family.
She is dedicated to equipping parents with reliable information and empowering them to make informed decisions with their children's physicians.
Passionate about alleviating parental isolation, Natalie ensures families feel seen, heard, and strengthened, fostering a supportive community where no parent walks their child's healing journey alone.
Natalie's calling is rooted in the belief that even in the darkest seasons, there is hope, help, and the possibility of healing. Her work brings vital support and connection to families navigating challenging medical landscapes.
Our goal is to enroll over a thousand patients in observational research studies by 2030.
Expanding our research network to more than 25 countries.
Every result we collect is published openly, whether positive or negative, so patients, physicians, and researchers can make better informed decisions.
We welcome researchers, medical writers, translators, and patient advocates to join our network of volunteers supporting observational research and education.
Your contributions support observational research, educational resources, and patient advocacy. Our application for recognition of tax-exempt status under Section 501(c)(3) is pending. Please consult your tax advisor about the deductibility of your gift.
Corporate sponsors, foundations, and healthcare organizations can amplify our impact through financial support, expertise sharing, and collaborative programs.
Patients and families may be eligible to take part in our observational studies. Your participation helps build open, public evidence about the safety and outcomes of emerging therapies.
A simple physician enrollment pathway for clinics and investigators seeking support for observational studies, patient registries, and real world outcomes tracking.
Healing Hope International works with qualified physicians and clinics to support observational studies and patient registries for emerging therapies, focused on real world outcomes and open publication of results.
Explore possibilities for your research idea.
You have a concept ready to implement.
Speak with an expert before proceeding.
A streamlined process designed for busy medical professionals.
Expert guidance for non-interventional research and patient data collection.
Robust frameworks to ensure reliable and compliant data capture.
Continued guidance as studies progress, at no cost to participating physicians.
Focused on real world outcomes and open publication of results.
Your generosity supports our observational research, educational resources, and patient advocacy.
Supports patient outreach and awareness
Funds advocacy work and policy reform
Supports our observational research registry
Healing Hope International is a Texas nonprofit corporation. Our application for recognition of tax-exempt status under Section 501(c)(3) of the Internal Revenue Code is pending. Please consult your tax advisor about the deductibility of your gift.
Help advance research on emerging therapies for patients and families.
Become a monthly donor. Even $10 a month adds up. Recurring gifts help us plan long term studies that follow patients for years.
Healing Hope International invites patients, families, clinicians, researchers, and mission aligned partners to join us in building open, trustworthy evidence about emerging therapies for serious and underserved conditions.
Stay informed about our research, published results, and educational resources by following us.
Healing Hope International is a research and education organization. We do not provide medical advice, treatment, or guarantee access to therapies. Many therapies referenced may be investigational and not approved for specific indications. These therapies may carry unknown risks, and outcomes are not guaranteed. Participation in observational research does not provide access to treatment.
All medical decisions should be made in consultation with a licensed healthcare provider.
Will Advancing the Understanding of Emerging Therapies Through Observational Research